Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies

被引:4
作者
Chandra, Anshuman [1 ]
Goyal, Nainee [1 ]
Qamar, Imteyaz [1 ]
Singh, Nagendra [1 ]
机构
[1] Gautam Buddha Univ, Sch Biotechnol, Greater Noida 201312, Uttar Pradesh, India
关键词
Molecular dynamics simulation; hot spot residues; cancer; specific inhibitors; PROCESSIVE PHOSPHORYLATION; SR;
D O I
10.1080/07391102.2020.1734487
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine-arginine protein kinase-1 (SRPK1) is a highly specific kinase that recognizes serine-arginine dipeptide repeats and phosphorylates SR rich splicing factor ASF/SF2 in a cell-cycle regulated manner. SRPK1 processively phosphorylates serine residues on its substrate ASF/SF2. Elevated expression pattern of both SRPK1 and ASF/SF2 and their association with various carcinomas have established SRPK1 as a potent target for drug design against cancers. In order to develop specific inhibitors the binding of ASF/SF2 to SRPK1 is desired to be selectively interrupted. We have performed molecular dynamics simulation studies on crystal structure of SRPK1 complex with ASF/SF2. The ASF/SF2 acquired a stable binding on the surface of SRPK1 with strong attractive forces. Analysis revealed that there was no major position shifting of the core beta-sheet region within the catalytic site of SRPK1 when present in the state of ASF/SF2 bound in comparison to apo form. Global motions of SRPK1 indicated that major stable structural changes occurred after the substrate binding. The interactions between SRPK1 and ASF/SF2 were examined and calculated during molecular dynamics simulation of 1 mu s. Molecular dynamics study indicated Arg84, Lys85, Leu86, Lys174, Tyr227 and Leu479 residues of SRPK1 as essential hot spots involved in the stable binding with substrate. Structural analysis of the binding affinity and hot spot investigation provided significant information on ASF/SF2 binding which may also be considered for designing of the novel specific inhibitors of SRPK1 for the applications in cancer therapy. Communicated by Ramaswamy H. Sarma
引用
收藏
页码:1579 / 1587
页数:9
相关论文
共 25 条
  • [1] Processive phosphorylation of alternative splicing factor/splicing factor 2
    Aubol, BE
    Chakrabarti, S
    Ngo, J
    Shaffer, J
    Nolen, B
    Fu, XD
    Ghosh, G
    Adams, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) : 12601 - 12606
  • [2] A PDB-wide, evolution-based assessment of protein-protein interfaces
    Baskaran, Kumaran
    Duarte, Jose M.
    Biyani, Nikhil
    Bliven, Spencer
    Capitani, Guido
    [J]. BMC STRUCTURAL BIOLOGY, 2014, 14
  • [3] The many faces of SRPK1
    Bullock, Nicholas
    Oltean, Sebastian
    [J]. JOURNAL OF PATHOLOGY, 2017, 241 (04) : 437 - 440
  • [4] Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion
    Bullock, Nicholas
    Potts, Jonathan
    Simpkin, Andrew J.
    Koupparis, Anthony
    Harper, Steve J.
    Oxley, Jon
    Oltean, Sebastian
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (02) : 171 - 175
  • [5] Identification and characterization of glyceraldehyde 3-phosphate dehydrogenase from Fasciola gigantica
    Chetri, Purna B.
    Shukla, Rohit
    Tripathi, Timir
    [J]. PARASITOLOGY RESEARCH, 2019, 118 (03) : 861 - 872
  • [6] Identification of Alternative Splicing Events Regulated by the Oncogenic Factor SRSF1 in Lung Cancer
    de Miguel, Fernando J.
    Sharma, Ravi D.
    Pajares, Maria J.
    Montuenga, Luis M.
    Rubio, Angel
    Pio, Ruben
    [J]. CANCER RESEARCH, 2014, 74 (04) : 1105 - 1115
  • [7] Structural studies on dihydrouridine synthase A (DusA) from Pseudomonas aeruginosa
    Goyal, Nainee
    Chandra, Anshuman
    Qamar, Imteyaz
    Singh, Nagendra
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 132 : 254 - 264
  • [8] A SERINE KINASE REGULATES INTRACELLULAR-LOCALIZATION OF SPLICING FACTORS IN THE CELL CYCLE
    GUI, JF
    LANE, WS
    FU, XD
    [J]. NATURE, 1994, 369 (6482) : 678 - 682
  • [9] Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy
    Gupta, Preeti
    Mohammad, Taj
    Khan, Parvez
    Alajmi, Mohamed F.
    Hussain, Afzal
    Rehman, Md Tabish
    Hassan, Md Imtaiyaz
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [10] Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma
    Hayes, GM
    Carrigan, PE
    Beck, AM
    Miller, LJ
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3819 - 3827